AWA Point
Author: Jeanette Jakobsson
India’s Supreme Court rejects patent plea by Novartis for the cancer drug Glivec
For years, India did not offer any patent protection for chemical compounds, but was obliged to do this after joining
Poverty versus patenting in India – round two
Earlier this year the first compulsory license, regarding the anti-cancer drug Sorafenib, was granted in India. (See previous blog
India Grants the First Compulsory License
The Compulsory License Application No. 1 of 2011, the first of its kind in the history of the Indian